Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Return-on-Tangible-Equity is calculated as Net Income divided by its average total shareholder tangible equity. Total shareholder tangible equity equals to Total Stockholders Equity minus Intangible Assets. Rafina Innovations's annualized net income for the quarter that ended in Mar. 2019 was $-2.49 Mil. Rafina Innovations's average shareholder tangible equity for the quarter that ended in Mar. 2019 was $-0.54 Mil. Therefore, Rafina Innovations's annualized Return-on-Tangible-Equity for the quarter that ended in Mar. 2019 was N/A%.
The historical rank and industry rank for Rafina Innovations's Return-on-Tangible-Equity or its related term are showing as below:
VICA's Return-on-Tangible-Equity is not ranked *
in the Medical Devices & Instruments industry.
Industry Median: 4.055 * Ranked among companies with meaningful Return-on-Tangible-Equity only.
Return-on-Tangible-Equity measures the rate of return on the ownership interest (shareholder's tangible equity) of the common stock owners. It measures a firm's efficiency at generating profits from every unit of shareholders' tangible equity (shareholders equity minus intangibles). Return-on-Tangible-Equity shows how well a company uses investment funds to generate earnings growth. Return-on-Tangible-Equitys between 15% and 20% are considered desirable.
Be Aware
Net Income is used.
Because a company can increase its Return-on-Tangible-Equity by having more financial leverage, it is important to watch the leverage ratio when investing in high Return-on-Tangible-Equity companies. Like Return-on-Tangible-Asset, Return-on-Tangible-Equity is calculated with only 12 months data. Fluctuations in company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.
Asset light businesses require very few assets to generate very high earnings. Their Return-on-Tangible-Equitys can be extremely high.
Rafina Innovations Return-on-Tangible-Equity Related Terms
Rafina Innovations Return-on-Tangible-Equity Historical Data
* Premium members only.
The historical data trend for Rafina Innovations's Return-on-Tangible-Equity can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
VICA vs RMSL, GTHP, DCTH: Return-on-Tangible-Equity Comparison
For the Medical Devices subindustry, Rafina Innovations's Return-on-Tangible-Equity, along with its competitors' market caps and Return-on-Tangible-Equity data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Rafina Innovations Return-on-Tangible-Equity vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Rafina Innovations's Return-on-Tangible-Equity distribution charts can be found below:
* The bar in red indicates where Rafina Innovations's Return-on-Tangible-Equity falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual Return-on-Tangible-Equity, the net income of the last fiscal year and the average total shareholder tangible equity over the fiscal year are used. In calculating the quarterly data,
the net income data used here is four times the quarterly (Mar. 2019) net income data.
Return-on-Tangible-Equity is displayed in the 10-year financial page.
What does a Return-on-Tangible-Equity of 0.00% mean?
Rafina Innovations (VICA) has a Return-on-Tangible-Equity of 0.00% as of Mar. 2019. Return on tangible equity is the ratio of current-period net income to average two-period tangible equity. View historical data on Rafina Innovations and its competitors.
Is Rafina Innovations' Return-on-Tangible-Equity too high?
Rafina Innovations' current Return-on-Tangible-Equity is 0.00%. Overall, Rafina Innovations has a GF Score™ of 12/100, reflecting its overall financial health beyond just this single metric.
How does Rafina Innovations' Return-on-Tangible-Equity compare to RMSL and GTHP?
Rafina Innovations' Return-on-Tangible-Equity of 0.00% can be compared against companies in the Medical Devices & Instruments industry. The industry median Return-on-Tangible-Equity is 4.06. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Return-on-Tangible-Equity for a Medical Devices & Instruments company?
The median Return-on-Tangible-Equity among Medical Devices & Instruments companies is 4.06, based on 758 companies in the industry. Companies in the top quartile (top 25%) have a Return-on-Tangible-Equity significantly above this median, while those in the bottom quartile fall well below. However, Return-on-Tangible-Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Return-on-Tangible-Equity mean?
A high Return-on-Tangible-Equity can signal that a stock is expensive relative to its fundamentals. Return on tangible equity is the ratio of current-period net income to average two-period tangible equity. View historical data on Rafina Innovations and its competitors. For the Medical Devices & Instruments industry, the median Return-on-Tangible-Equity is 4.06 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Rafina Innovations's current Return-on-Tangible-Equity is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Rafina Innovations stock overvalued right now?
Rafina Innovations (VICA) has a current Return-on-Tangible-Equity of 0.00%. The current Return-on-Tangible-Equity is 0.00%. Rafina Innovations' overall GF Score™ is 12/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Return-on-Tangible-Equity calculated?
Return-on-Tangible-Equity is calculated from a company's financial statements. For Rafina Innovations (VICA), the current Return-on-Tangible-Equity is 0.00% as of Mar. 2019. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Rafina Innovations Inc through its subsidiaries is involved in the development of monitoring technologies, set up of rehabilitation centers, development of intellectual property related to everyday fields such as healthcare, sports, automotive and gaming as well as the creation of full-service Prosthetics and Orthotics and Diabetic foot clinics chain in Europe and the Middle East. The firm's main products include Flexisense technology and Rehabilitation clinics etc. It has Clinics and Technology operating segments and derives a majority of its revenues from Clinics segment.
12GF Score
Get the complete analysis for VICA
Return-on-Tangible-Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
VICA has been successfully added to your 
